AU2002211142A1 - Screening method using a g coupled receptor associated with a specific g protein - Google Patents

Screening method using a g coupled receptor associated with a specific g protein

Info

Publication number
AU2002211142A1
AU2002211142A1 AU2002211142A AU1114202A AU2002211142A1 AU 2002211142 A1 AU2002211142 A1 AU 2002211142A1 AU 2002211142 A AU2002211142 A AU 2002211142A AU 1114202 A AU1114202 A AU 1114202A AU 2002211142 A1 AU2002211142 A1 AU 2002211142A1
Authority
AU
Australia
Prior art keywords
protein
specific
screening method
coupled receptor
receptor associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211142A
Inventor
Bertil Fredholm
Bjorn Kull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACTAR AB
Original Assignee
ACTAR AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ACTAR AB filed Critical ACTAR AB
Publication of AU2002211142A1 publication Critical patent/AU2002211142A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002211142A 2000-10-26 2001-10-24 Screening method using a g coupled receptor associated with a specific g protein Abandoned AU2002211142A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24329400P 2000-10-26 2000-10-26
US60243294 2000-10-26
PCT/SE2001/002323 WO2002035231A1 (en) 2000-10-26 2001-10-24 Screening method using a g coupled receptor associated with a specific g protein

Publications (1)

Publication Number Publication Date
AU2002211142A1 true AU2002211142A1 (en) 2002-05-06

Family

ID=22918166

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211142A Abandoned AU2002211142A1 (en) 2000-10-26 2001-10-24 Screening method using a g coupled receptor associated with a specific g protein

Country Status (2)

Country Link
AU (1) AU2002211142A1 (en)
WO (1) WO2002035231A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015164378A1 (en) * 2014-04-22 2015-10-29 Q-State Biosciences, Inc. Analysis of compounds for pain and sensory disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691188A (en) * 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
ATE257156T1 (en) * 1997-03-24 2004-01-15 Kyowa Hakko Kogyo Kk (1,2,4)TRIAZOLO(1,5-C)PYRIMIDINE DERIVATIVES
JP2003517423A (en) * 1997-07-29 2003-05-27 メドコ リサーチ、インコーポレイテッド N6-substituted adenosine-5'-uronamide as adenosine receptor modulator
US6197788B1 (en) * 1997-11-26 2001-03-06 Vernalis Research Limited (−)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders
US20020015967A1 (en) * 1998-06-02 2002-02-07 Lauren Silverman Functional expression of adenosine receptors in yeast

Also Published As

Publication number Publication date
WO2002035231A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2001295757A1 (en) A shale shaker
AU2001268471A1 (en) G-protein coupled receptors
AU1290001A (en) Antibodies
AUPP904499A0 (en) A screening apparatus
AU2001234766A1 (en) G-protein coupled receptors
AU2001264721A1 (en) G-protein coupled receptors
AU2001280785A1 (en) G-protein coupled receptors
EP1469316A2 (en) Screening method
AU7433900A (en) Screening methods
AU2001246934A1 (en) Agonist antibodies
IL148266A0 (en) Apo-2 receptor antibodies
AU2001251175A1 (en) G-protein coupled receptors
AU2002239291A1 (en) G protein coupled receptors
AU2001296444A1 (en) G-protein coupled receptors
AU2001261814A1 (en) G-protein coupled receptors
EP1189944A4 (en) Axor16, a g protein coupled receptor
AU1553101A (en) Screening method
AU2001240019A1 (en) G-protein coupled receptors
AU2452301A (en) Protein methylarginine-specific antibodies
AU6429000A (en) Screening method
AU2002210585A1 (en) Method for modifying a protein structure
AU2002211142A1 (en) Screening method using a g coupled receptor associated with a specific g protein
AU2002351899A1 (en) Method for tasting structural materials fatigue
AUPQ563400A0 (en) Novel receptor
AU2001223882A1 (en) Receptor